Hongbing W. Ma
No. 157, Xiwu Road
Xi'an, 710004, China
Xi'an, 710004, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Causal roles of immune cells and plasma metabolites in esophageal cancer: A Mendelian randomization study with nutritional insights.
Journal: Asia Pacific journal of clinical nutrition
Published: January 21, 2026
The PRKN/METTL3/CLDN2 axis promotes colorectal cancer development through epigenetic mechanisms.
Journal: Cell biology and toxicology
Published: January 09, 2026
Association between four indirect indicators of insulin resistance and lung cancer: evidence from UK biobank and Mendelian randomization analysis.
Journal: BMC cancer
Published: December 01, 2025
Corrigendum to 'Simvastatin inhibits the development of radioresistant esophageal cancer cells by increasing the radiosensitivity and reversing EMT process via the PTEN-PI3K/AKT pathway' [Exp Cell Res. 2018 Jan 15;362(2):362-369].
Journal: Experimental cell research
Published: October 17, 2025
Long noncoding RNA PCAT7 confers radioresistance of esophageal squamous cell carcinoma by promoting GCLM-mediated anti-ferroptosis.
Journal: Journal of translational medicine
Published: August 10, 2025
Comprehensive analysis of FAM83B in pan-cancer and preliminary exploration in esophageal squamous cell carcinoma.
Journal: Journal of molecular histology
Published: March 06, 2025
N6-methyladenosine-mediated upregulation of LNCAROD confers radioresistance in esophageal squamous cell carcinoma through stabilizing PARP1.
Journal: Clinical and translational medicine
Published: June 13, 2024
METTL3 in cancer-associated fibroblasts-derived exosomes promotes the proliferation and metastasis and suppresses ferroptosis in colorectal cancer by eliciting ACSL3 m6A modification.
Journal: Biology direct
Published: May 21, 2024
Causal associations between constipation and pan-cancer: a bidirectional Mendelian randomization study.
Journal: Frontiers in oncology
Published: May 05, 2024
CD39 inhibitor (POM-1) enhances radiosensitivity of esophageal squamous cell carcinoma (ESCC) cells by promoting apoptosis through the Bax/Bcl-2/Caspase 9/Caspase 3 pathway.
Journal: International immunopharmacology
Published: February 04, 2024
Innovative regression model-based decision support tool for optimizing radiotherapy techniques in thoracic esophageal cancer.
Journal: Frontiers in oncology
Published: January 14, 2024
Drug repurposing: insights into the antimicrobial effects of AKBA against MRSA.
Journal: AMB Express
Published: November 04, 2023
Last Updated: 09/26/2026